Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Frontiers in Medicine|June 1, 2022
A Regulatory Risk-Based Approach to ATMP/CGT Development: Integrating Scientific Challenges With Current Regulatory ExpectationsLaura I Salazar-FontanaEuropean Journal of Immunology|June 9, 2005
The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cellsMónica Gumá, Lisa K Busch, Laura I Salazar-Fontana, et al.The AAPS Journal|January 14, 2017
Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug DevelopmentLaura I Salazar-Fontana, Dharmesh D Desai, Tarik A Khan, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Adaptable TCR avidity thresholds for negative selectionMilica Stojakovic, Laura I Salazar-Fontana, Zohreh Tatari-Calderone, et al.Mabs|March 5, 2024
Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Daniel Baltrunkonis, Sofie Denies, et al.Pageof 1